Connect Today, Improve Patient Care Tomorrow!
The Oncology Connection is a quarterly newsletter with the goal of providing APPs practical and clinically relevant information that will allow them to optimally provide direct patient care including patient counseling, prescribing and managing treatments, and handling follow-up patient visits.
Sign Up For the Newsletter!
Read our Latest Posts
Head and Neck caB
Although risk factors for squamous-cell cancer of the head and neck (SCCHN) have been identified (e.g., tobacco use, alcohol use, human papilloma virus [HPV] infection), the impact of social determinants of health (SDH) in patients with SCCHN has been poorly characterized. Moreover, population-based studies assessing this question have been lacking.
Enfortumab vedotin-ejfv (PADCEV)
Bladder cancer is the sixth most common cancer in the United States. Patients with locally advanced or metastatic disease have poor long-term survival, especially those who have progressed after chemotherapy and immunotherapy. A new agent, enfortumab vedotin-ejfv (PADCEV, Astellas Pharma US, Inc.), may provide such patients with a viable and effective treatment option.
Erdafitinib for the Treatment of Urothelial Carcinoma
Erdafitinib (Balversa®, Janssen Products, LP) is a novel fibroblast growth factor receptor (FGFR) inhibitor recently approved by the FDA for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma with a susceptible FGFR3 or FGFR2 genetic alteration who have progressed during or following at least one prior line of platinum-containing chemotherapy.
Serving as Team Lead in a Quality Improvement Project
Quality Improvement (QI) in the healthcare setting has evolved in recent years to improve outcomes in clinical practice.1 In 2010, the American Society of Clinical Oncology (ASCO) implemented the Quality Oncology Practice Initiative (QOPI®) Certification program to evaluate practice performance against quality measures and standards established by experts in the oncology field.2 Quality Improvement initiatives may lead to better patient outcomes, consistent high quality safe and effective care, and professional engagement in career development.
Engaging Specialty Pharmacies to Help Patients Cover the Cost of Therapy
According to recent studies, nearly 1 in 4 adults in the United States who are taking prescription medications, expressed difficulty affording their prescription drugs. After a large spike in costs in 2014, prescription drug costs are expected to represent about 10% of U.S. healthcare costs over the next six years.